Coppell Advisory Solutions Corp. Vigil Neuroscience, Inc. Transaction History

Coppell Advisory Solutions Corp.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 10, 2023	BUY	$8.77 - $12.7 $26,292 - $38,074	2,998 Added 999.33%	3,298 $502 Million
Q4 2022 Feb 17, 2023	BUY	$9.38 - $15.75 $2,814 - $4,725	300 New	300 $45.6 Million

26.7M

Ticker VIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,268,600
Market Cap $113M
Description
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions Corp., based on Form 13F filings with the SEC.

Stay updated on Coppell Advisory Solutions Corp. with notifications on news.